- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06151158
Prevención del comportamiento suicida en diversos jóvenes de alto riesgo en entornos de cuidados intensivos (Project HOPE)
This multisite randomized controlled trial will compare two brief interventions for youth and young adults ages 12-24 following an acute care visit for suicide risk: the Stanley-Brown Safety Planning Intervention with follow-up contacts (SPI+) and Interpersonal Psychotherapy for Adolescents-Ultra Short Crisis Intervention (IPT-A SCI). The study will evaluate which approach is more effective in reducing suicidal ideation and suicide events. Findings will help patients, families, and clinicians make informed decisions about care following a suicide-related emergency department visit.
Descripción general del estudio
Estado
Descripción detallada
Youth and young adults who present to emergency departments (EDs) with suicide-related concerns need timely access to effective interventions and follow-up care. However, evidence is limited regarding which brief interventions are most effective for this population. This study focuses on youth and young adults ages 12-24 receiving care in five racially and ethnically diverse geographic areas: Philadelphia, Pennsylvania; Baltimore, Maryland; Chapel Hill, North Carolina; St. Petersburg, Florida; and New York City, New York.
This multisite randomized controlled trial compares two brief interventions: the Safety Planning Intervention with follow-up contacts (SPI+) and Interpersonal Psychotherapy for Adolescents-Ultra Short Crisis Intervention (IPT-A SCI). SPI+ is a suicide-specific intervention that helps participants recognize warning signs and identify coping strategies and sources of support to prevent suicidal crises from escalating. It combines safety planning in the acute care setting with follow-up contacts. IPT-A SCI is a brief psychotherapy intervention delivered primarily in outpatient settings that addresses interpersonal problems associated with suicidal crises and helps participants develop communication and interpersonal problem-solving skills.
The study will examine the comparative effectiveness of these interventions in reducing suicidal ideation and suicide events among youth and young adults following an acute care visit for suicide risk. Although both approaches are intended to support participants during periods of elevated risk, the approaches differ in focus, intensity, and delivery setting. Understanding comparative effectiveness can help guide treatment decisions, implementation, and resource allocation across acute care and outpatient settings.
The research team works with a racially and ethnically diverse group of partners and advisors, including advocates, researchers, ED physicians, nurses, social workers, and individuals with lived experience of suicide attempts or suicide loss. Partners and advisors have contributed to recruitment strategies, intervention approaches, and follow-up procedures and will continue to inform study conduct, interpretation of findings, and dissemination.
Findings from this study will help inform care for youth and young adults presenting to EDs with suicide-related concerns and support the implementation of effective, brief interventions across diverse clinical settings.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Holly C Wilcox, PhD
- Número de teléfono: 410-370-0081
- Correo electrónico: hwilcox1@jhmi.edu
Copia de seguridad de contactos de estudio
- Nombre: Catherine Grela
- Número de teléfono: 667-217-4303
- Correo electrónico: agrelam1@jh.edu
Ubicaciones de estudio
-
-
Florida
-
St. Petersburg, Florida, Estados Unidos, 33701
- Reclutamiento
- Johns Hopkins All Children's Hospital
-
Contacto:
- Jennifer Katzenstein, PhD
- Número de teléfono: 727-767-7439
- Correo electrónico: jkatzen7@jhmi.edu
-
Contacto:
- Jasmine Niazi, M.S.
- Número de teléfono: 727-767-2389
- Correo electrónico: jniazi1@jh.edu
-
Investigador principal:
- Jennifer Katzenstein, PhD
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21205
- Reclutamiento
- Johns Hopkins University
-
Contacto:
- Holly C. Wilcox, PhD
- Número de teléfono: 410-370-0081
- Correo electrónico: hwilcox1@jhmi.edu
-
Investigador principal:
- Holly C Wilcox, PhD
-
Contacto:
- Catherine Grela
- Número de teléfono: 667-217-4303
- Correo electrónico: agrelam1@jh.edu
-
-
New York
-
New York, New York, Estados Unidos, 10032
- Reclutamiento
- Columbia University Irving Medical Center (CUMC)
-
Contacto:
- Laura Mufson, PhD
- Número de teléfono: 646-774-5791
- Correo electrónico: Lhm3@cumc.columbia.edu
-
Contacto:
- Christa Labouliere, PhD
- Número de teléfono: 646-774-8467
- Correo electrónico: Christa.Labouliere@nyspi.columbia.edu
-
Investigador principal:
- Laura Mufson, PhD
-
Sub-Investigador:
- Christa Labouliere, PhD
-
New York, New York, Estados Unidos, 10065
- Reclutamiento
- Weill-Cornell Medicine
-
Contacto:
- Shannon Bennett, PhD
- Número de teléfono: 646-962-2820
- Correo electrónico: smb9017@med.cornell.edu
-
Contacto:
- Gail Harrison
- Número de teléfono: 929-646-0627
- Correo electrónico: gah4007@med.cornell.edu
-
Investigador principal:
- Shannon Bennett, PhD
-
-
North Carolina
-
Chapel Hill, North Carolina, Estados Unidos, 27514
- Reclutamiento
- University of North Carolina Medical Center
-
Contacto:
- Danielle Lowe, MD, PhD
- Número de teléfono: 919-445-0870
- Correo electrónico: Danielle_Lowe@med.unc.edu
-
Contacto:
- Rachel Ear, PhD
- Número de teléfono: 919-445-0870
- Correo electrónico: earr@unc.edu
-
Investigador principal:
- Danielle Lowe, MD, PhD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- Reclutamiento
- Childrens Hospital of Philadelphia
-
Contacto:
- Tami Benton, MD
- Número de teléfono: 609-351-2637
- Correo electrónico: bentont@chop.edu
-
Contacto:
- Juan Zambonini, PhD
- Número de teléfono: 215-839-6617
- Correo electrónico: zamboninij@email.chop.edu
-
Investigador principal:
- Tami Benton, PhD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Suicide Risk During Acute Care Visit (At least one item must apply: Chief complaint of suicide-related concern, Active suicidal ideation endorsed in past 1 month on validated suicide screener, Suicidal behavior in the past 3 months on validated suicide screener, and/or Clinician indicated SI in past month or SA in past 3 months).
- Have access to a cellular phone with the ability to receive phone calls and text messages over the 12-month follow- up period
- Adolescent must be verbally fluent and can communicate, understand, and read in either English or Spanish
- Adolescent has been/will be discharged from a higher level of care (i.e. inpatient, day hospital, partial hospitalization program (PHP), or residential treatment program) and back in the community within 4 weeks of the acute care visit.
Exclusion Criteria:
- Significant cognitive or developmental delays that prevent understanding or using SPI+ or IPT-A-SCI (includes inability to communicate verbally)
- Altered mental status (acute psychosis, intoxication, or mania)
- Unable or unwilling to provide informed consent (adults), assent (minors), or permission (parents/caregivers)
- The services offered through the study are not in the best clinical interest of the patient (e.g., presenting problem requires a different level of care or treatment approach).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Safety Planning Intervention (SPI)
The SPI is a brief, evidence- based intervention that provides people with an individualized set of steps that can be used progressively to both reduce risk and maintain safety when suicide ideation (SI) emerges. Safety plans are developed collaboratively between providers, at risk youth, and family members when possible. Core SPI components include recognizing warning signs of an imminent suicidal crisis (e.g., changes in mood, thoughts or behaviors); using internal coping skills to reduce distress; using people or places in the individual's support network as a means of distraction from SI; reaching out to family or friends to help manage the crisis; contacting health professionals or emergency services; and reducing access to lethal means. SPI+ includes a brief follow-up component post- discharge that includes contacting the patient for a mood and risk check-in; reviewing and revising the safety plan; and facilitating connection with community mental health services. |
Stanley Brown Safety Planning completed in the emergency department with 3 follow-up contacts after discharge |
|
Comparador activo: Ultra-Brief Crisis Interpersonal Psychotherapy for Suicidal Children and Adolescents (IPT-A-SCI)
Ultra-Brief Crisis Interpersonal Psychotherapy for Suicidal Children and Adolescents (IPT-A-SCI) is a scalable, flexible, and extensively examined mental health treatment developed to reduce depressive symptoms and improve interpersonal functioning, and has been adapted for use in adolescents (IPT-A-SCI) and shown to be effective in treating depression and reducing associated suicide risk. Interpersonal problems are often at the core of suicidal thinking and behavior in youths including minority youths. |
Five session crisis focused version of IPT for adolescents. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Suicidal ideation as assessed by the Suicide Assessment Five-step Evaluation and Triage (SAFE-T) with Columbia-Suicide Severity Rating Scale (C-SSRS) Recent
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
Suicidal thoughts: measured using the Suicide Assessment Five-step Evaluation and Triage (SAFE-T) with Columbia-Suicide Severity Rating Scale (C-SSRS) Recent. Scores for suicidal ideation range from 0 to 5, with higher scores indicating more serious suicidal ideation, where 0 = "no suicidal thoughts"; 1= "wish to be dead"; 2 = "nonspecific active suicidal thoughts"; 3 = "suicidal thoughts with methods"; 4 = "suicidal intent"; and 5 = "suicidal intent with plan". |
baseline, 3 months, 6 months, 12 months
|
|
Suicide events: measured using the Columbia-Suicide Severity Rating Scale (C-SSRS) and the Service Assessment for Children and Adolescents (SACA) Recent
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
Suicide event is defined as the presence of a suicide attempt, an aborted or interrupted attempt (as identified on the C-SSRS), or a visit to the emergency department, crisis stabilization acute care facility, or psychiatric hospitalization for suicide-related concerns (as identified on the SACA) occurring anytime during the follow-up period. |
baseline, 3 months, 6 months, 12 months
|
|
Number of Suicides
Periodo de tiempo: 12 months
|
Measured through Death Records or Suicide from Office of Chief Medical Examiner, family report or medical record |
12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Frequency of mental health service utilization as assessed by Services Assessment for Children and Adolescents (SACA)
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
Services Assessment for Children and Adolescents (SACA) use of inpatient, outpatient, school services since last assessment. Items are dichotomous (yes/no) and the scale ranges from 0 (no services) to 3 (3 types of services), higher numbers indicate more services. |
baseline, 3 months, 6 months, 12 months
|
|
Change in Self reported Quality of Life as assessed by the Euro-Qol 5-Dimension 3-level tool (EQ-5D-3L)
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
Euro-Qol 5-Dimension 3-level tool (EQ-5D-3L) for young adults. The scale consists of a descriptive system that comprises five items referring to the domains mobility, self-care, usual activities, pain/discomfort and anxiety/depression scored as presenting no problems, moderate problems or severe problems. Each of the five items (range 0-2) with higher scores indicating better quality of life. A component of this scale is the EuroQol visual analogue scale (EQ-VAS) which participants can use a number from 0 (the worst) -100 (the best health state imaginable). |
baseline, 3 months, 6 months, 12 months
|
|
Change in Self reported Quality of Life as assessed by the Euro-Qol 5-Dimension Youth (EQ-5D-Y)
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
Quality of Life will be assessed by the Euro-Qol 5-Dimension Youth (EQ-5D-Y). The scale consists of a descriptive system that comprises five items referring to the domains mobility, self-care, usual activities, pain/discomfort and anxiety/depression scored as presenting no problems, moderate problems or severe problems. Each of the five items (range 0-2) with higher scores indicating better quality of life. A component of this scale is the EuroQol visual analogue scale (EQ-VAS) which participants can use a number from 0 (the worst) -100 (the best health state imaginable). |
baseline, 3 months, 6 months, 12 months
|
|
Change in Generalized Anxiety Disorder as assessed by the The Generalized Anxiety Disorder 7 question scale (GAD-7).
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
Generalized Anxiety Disorder will be assessed by the GAD 7 question scale. The Generalized Anxiety Disorder 7 is a self-reported questionnaire for screening and severity measuring of generalized anxiety disorder. The GAD-7 total score ranges from 0 to 21 with clinical categorizations of anxiety levels as follows: GAD-7 score of 0-4 (none), 5-9 (mild), 10-14 (moderate), and 15-21 (severe). |
baseline, 3 months, 6 months, 12 months
|
|
Change in Depression severity as assessed by the nine-item Patient Health Questionnaire (PHQ-9).
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
The nine-item Patient Health Questionnaire is a depressive symptom scale and diagnostic tool that assesses the presence and severity of depressive symptoms and a possible depressive disorder. The PHQ-9 total score ranges from 0 to 27 (scores of 5-9 are classified as mild depression; 10-14 as moderate depression; 15-19 as moderately severe depression; ≥ 20 as severe depression). |
baseline, 3 months, 6 months, 12 months
|
|
Change in conflicts with family members as assessed by the Conflict Behavior Questionnaire (CBQ).
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
The Conflict Behavior Questionnaire (CBQ) reliably assesses the adolescent's perception of the relationship with the participant's parents. The CBQ total score ranges from 0-20, with higher scores indicating greater conflict with each parent. |
baseline, 3 months, 6 months, 12 months
|
|
Change in social interactions with peers as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Peer Relationships scale.
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
The PROMIS (Patient-Reported Outcomes Measurement Information System) scale assesses social interactions with peers. The Pediatric Peer Relationships scale has a possible score between 1 and 40, with higher scores indicating greater social interactions with peers. |
baseline, 3 months, 6 months, 12 months
|
|
Change in social interactions with family as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Family Relationships scale.
Periodo de tiempo: baseline, 3 months, 6 months, 12 months
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) scale assesses social interactions with family. The Pediatric Family Relationships scale has a possible score between 1 and 40, with higher scores indicating greater social interactions with family. |
baseline, 3 months, 6 months, 12 months
|
|
Change in skill use derived from the Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+) arm
Periodo de tiempo: 3 months, 6 months, 12 months
|
Project-created a self-report of Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+) skill use during follow-up, indicating feasibility/acceptability of SPI, helpfulness of different skills/sections of the safety plan, and frequency of use for different skills/sections of the safety plan. |
3 months, 6 months, 12 months
|
|
Change in skill use derived from the Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI) arm
Periodo de tiempo: 3 months, 6 months, 12 months
|
Project created a self-report of Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI) skill use during follow-up indicating which components adolescents have used. The self-report survey scoring will be a summation and then taking an average of the sum to be the score. Higher scores closer to 5 indicate adolescents learned a lot of from the intervention, and the lower scores indicate adolescents learned few skills. |
3 months, 6 months, 12 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Holly C Wilcox, PhD, Johns Hopkins Bloomberg School of Public Health
Publicaciones y enlaces útiles
Publicaciones Generales
- Stanley B, Brown GK, Brenner LA, Galfalvy HC, Currier GW, Knox KL, Chaudhury SR, Bush AL, Green KL. Comparison of the Safety Planning Intervention With Follow-up vs Usual Care of Suicidal Patients Treated in the Emergency Department. JAMA Psychiatry. 2018 Sep 1;75(9):894-900. doi: 10.1001/jamapsychiatry.2018.1776.
- Haruvi Catalan L, Levis Frenk M, Adini Spigelman E, Engelberg Y, Barzilay S, Mufson L, Apter A, Benaroya Milshtein N, Fennig S, Klomek AB. Ultra-Brief Crisis IPT-A Based Intervention for Suicidal Children and Adolescents (IPT-A-SCI) Pilot Study Results. Front Psychiatry. 2020 Dec 9;11:553422. doi: 10.3389/fpsyt.2020.553422. eCollection 2020.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Procesos Patológicos
- Atributos de la enfermedad
- Síntomas de comportamiento
- Comportamiento auto agresivo
- Condiciones Patológicas, Signos y Síntomas
- Comportamiento
- Prevención del Suicidio
- Emergencias
- Suicidio
- Suicidio, Intento
- Psicoterapia
- Disciplinas y actividades de comportamiento
- Psicoterapia interpersonal
Otros números de identificación del estudio
- IRB00408733
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .